Equagesic

   
Google
 
Web NewDrugInformation.com

Equagesic


Drug - Equagesic
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Aspirin; Meprobamate
Multiple ingredients are in alphabetical order.

Strength - 325MG;200MG
The potency of the active ingredient(s), Aspirin; Meprobamate. May repeat for multiple part products.

Applicant - LEITNER PHARMS
The firm name holding legal responsibility for Equagesic. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 011702
The FDA assigned number to Equagesic. Format is nnnnnn.

Product Number - 003
The FDA assigned number to identify Equagesic. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Dec 29, 1983
The date Equagesic was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Equagesic. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Equagesic is in. Format is RX, OTC, DISCN.

Applicant Full Name - Leitner Pharmaceuticals Llc
The full name of the firm holding legal responsibility for the new application of Equagesic.

Equagesic